A recent funding round for DarioHealth Corp. (NASDAQ: DRIO) was dominated by ongoing backing from established long-term institutional investors, along with contribution from a fresh global fundamental institutional investor. The financing, announced in New York on July 22, 2026, saw significant support for the company.